Home/Filings/4/0000929638-23-002767
4//SEC Filing

GHALIE RICHARD G 4

Accession 0000929638-23-002767

CIK 0001262104other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 7:38 PM ET

Size

5.1 KB

Accession

0000929638-23-002767

Insider Transaction Report

Form 4
Period: 2023-09-29
GHALIE RICHARD G
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-29+30,00030,000 total
    Exercise: $7.01Exp: 2033-09-29Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001156208

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 7:38 PM ET
Size
5.1 KB